Market Research Logo

Global Urticaria Drugs Market 2018-2022

Global Urticaria Drugs Market 2018-2022

About this market

Urticaria is a vastly prevalent disorder resulting in high medical consultations globally. The increase in risk factors for urticaria like latent infectious, chronic inflammatory diseases, autoreactivity and alcohol consumption. Though the incident is increasing, and it is negatively impacting the quality of life of the people, most patients are undertreated due to challenges in affordability of drugs and low access to healthcare due to social stigma. Technavio’s analysts have predicted that the urticaria drugs market will register a CAGR of over 10% by 2022.

Market Overview

Guidelines for management of urticaria patients

The management guidelines include clinical classification, etiology, investigations, diagnosis, treatment guidance along with special sections on children suffering from urticaria and the use of antihistamines in pregnant women or breastfeeding women.

High cost of urticaria management

The high medication costs along with the indirect costs are expected to put low- income patients at danger for suboptimal treatment and an increased burden due to poorly controlled disease.

For the detailed list of factors that will drive and challenge the growth of the urticaria drugs market during the 2018-2022, view our report.

Competitive Landscape

The global urticaria drugs market is moderately concentrated and the market being in a growth phase, the competition among companies is intense. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.


PRESS RELEASE

Technavio Announces the Publication of its Research Report – Global Urticaria Drugs Market 2018-2022

Technavio recognizes the following companies as the key players in the global urticaria drugs market: F. Hoffmann-La Roche (Genentech), JDP Therapeutics, Meiji Holdings, Novartis, Taiho Pharmaceutical.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the introduction of biologics for the treatment of urticaria.”

According to the report, one of the major drivers for this market is the guidelines for management of urticaria patients.

Further, the report states that one of the major factors hindering the growth of this market is the high cost of urticaria management.

Companies Mentioned

F. Hoffmann-La Roche (Genentech)

JDP Therapeutics

Meiji Holdings

Novartis

Taiho Pharmaceutical

  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global dermatological drugs market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Urticaria pipeline analysis
      • Table Pipeline drugs for urticaria
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global - Market size and forecast 2017-2022 ($ mn)
      • Table Global - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • By type of drug
    • Segmentation by type of drug
    • Antihistamines
    • Anti-inflammatory agents
    • Sulfones
    • Biologics
  • Market segmentation by application
    • Segmentation by application
      • Table Application - Market share 2017-2022 (%)
    • Comparison by application
      • Table Comparison by application
    • Acute urticaria - Market size and forecast 2017- 2022
      • Table Acute urticaria - Market size and forecast 2017-2022 ($ mn)
      • Table Acute urticaria - Year-over-year growth 2018-2022 (%)
    • Chronic urticaria - Market size and forecast 2017- 2022
      • Table Chronic urticaria - Market size and forecast 2017-2022 ($ mn)
      • Table Chronic urticaria - Year-over-year growth 2018-2022 (%)
    • Market opportunity by application
      • Table Market opportunity by application
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global - Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • EMEA - Market size and forecast 2017-2022
      • Table EMEA - Market size and forecast 2017-2022 ($ mn)
      • Table EMEA - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • Americas - Market size and forecast 2017-2022
      • Table Americas - Market size and forecast 2017-2022 ($ mn)
      • Table Americas - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • APAC - Market size and forecast 2017-2022
      • Table APAC - Market size and forecast 2017-2022 ($ mn)
      • Table APAC - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Introduction of biologics for the treatment of urticaria
    • International guidelines for diagnosis and management of urticaria
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • F. Hoffmann-La Roche (Genentech)
      • Table F. Hoffmann-La Roche (Genentech) – Overview
      • Table F. Hoffmann-La Roche (Genentech) - Business segments
      • Table F. Hoffmann-La Roche (Genentech) - Organizational developments
      • Table F. Hoffmann-La Roche (Genentech) - Geographic focus
      • Table F. Hoffmann-La Roche (Genentech) - Segment focus
      • Table F. Hoffmann-La Roche (Genentech) - Key offerings
    • JDP Therapeutics
      • Table JDP Therapeutics – Overview
      • Table JDP Therapeutics - Business segments
      • Table JDP Therapeutics - Organizational developments
      • Table JDP Therapeutics - Key offerings
    • Meiji Holdings
      • Table Meiji Holdings - Overview
      • Table Meiji Holdings - Organizational developments
      • Table Meiji Holdings - Key offerings
    • Novartis
      • Table Novartis – Overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis - Geographic focus
      • Table Novartis - Segment focus
      • Table Novartis - Key offerings
    • Taiho Pharmaceutical
      • Table Taiho Pharmaceutical - Overview
      • Table Novartis - Organizational developments
      • Table Taiho pharmaceutical - Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report